CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
Peripheral Blood Mononuclear Cells: A Brief Review
Peripheral blood mononuclear cells (PBMCs) are a diverse mixture of highly specialized immune cells that play key roles in keeping our bodies healthy. This brief review tells a short story about PBMCs starting with their origin, the different immune cells within the PBMC fraction, isolation of these cells and how to characterize them, and once isolated and characterized, how these cells benefit medical research. By Tera Muir, PhD. Origin of Peripheral Blood Mononuclear Cells The Frequency of Different Cell Populations within the…
Read MoreEarly Detection of Cancer from a Single Blood Draw
How can a single blood draw detect cancer early in disease progression? The National Cancer Institute estimates 1,735,350 new cases of cancers with mortality exceeding 600,000 this year in the US alone. It is therefore imperative to find an early detection system and effective treatment of these cancers to help ease the mortality rate. Early detection refers to measures that can be taken to diagnose cancer as early as possible when the disease is easiest to treat. These measures include annual screens such…
Read MoreMEA’S STORY
My life changed on May 6, 2006 I remember leaving my house to go shopping. Like many times before, I was driving on the highway and listening to music. After that my next memory is waking up in the emergency room. When I opened my eyes, I remember my family and friends looking down at me crying. When I tried to speak I was unable to form a complete sentence. I started to cry. I had no idea how I had ended…
Read MoreSan Diego Stem Cell Collection Center Open House: 12/3/18
YOU’RE INVITED StemExpress is having an open house for our San Diego Stem Cell Collection Center! We are a life-science company dedicated to supporting researchers globally by providing high-quality human biospecimens including peripheral blood, T-cells and Leukopaks® – and it all starts at our collection center. WHEN: Monday, 12/3 TIME: 12 pm – 5 pm WHERE: 4520 Executive Drive, Suite 350 | San Diego, CA 92121 [button title=”RSVP here” link=”https://events.r20.constantcontact.com/register/eventReg?oeidk=a07efsuk8fie5c28fb6&oseq=&c=&ch=” target=”_blank” align=”” icon=”” icon_position=”” color=”blue” font_color=”white” size=”2″ full_width=”” class=”” download=”” rel=”” onclick=””]…
Read MoreRockville Stem Cell Collection Center Open House and Ribbon Cutting: 11/30/18
YOU’RE INVITED StemExpress is having an open house for our newest stem cell collection center! We are a life-science company dedicated to supporting researchers globally by providing high-quality human biospecimens including peripheral blood, T-cells and Leukopaks® – and it all starts at our collection center. WHEN: Tuesday, 11/13 TIME: 12 pm – 5 pm WHERE: 9707 Medical Center Drive, Suite 230 | Rockville, MD 20850 [button title=”RSVP here” link=”http://events.constantcontact.com/register/event?llr=v4pzvt6ab&oeidk=a07eftaea2e7d6f0c20″ target=”_blank” align=”” icon=”” icon_position=”” color=”blue” font_color=”white” size=”2″ full_width=”” class=””…
Read MoreCGT Global Partners with Biological Industries
StemExpress partners with Biological Industries USA regarding the non-exclusive global distribution of our well-defined high-quality Mesenchymal Stem Cells (MSCs). With the addition of our MSCs, Biological Industries, a leading cell culture media developer and manufacturer, now offers a full cell culture solution to their clients. Using Biological Industries’ NutriStem® MSC Medium, a completely defined serum-free, xeno-free, low-protein formula medium, in combination with StemExpress’ MSCs researchers and clinicians can produce clinical-quality MSCs for their research needs. Check out their latest Application Note and see how…
Read MoreCGT GLOBAL FOUNDATION SEPTEMBER 2018 MAMAROO® 4 GIVEAWAY WINNER
Congratulations to Michelle, the lucky winner of our StemExpress Foundation September 2018 mamaRoo® 4 Giveaway! Wishing you and your family lots of joy with your new addition. For other moms-to-be, you’re invited to participate in a project to help develop more accurate prenatal testing. Appointments generally take 30-45 minutes at any StemExpress Stem Cell Collection Center. Maternal blood donors are offered $50 for their time and effort in the form of a Visa® gift card. Call 877.900.STEM to schedule your appointment today.
Read MoreCGT Global Exhibiting at NIH: Research Festival Exhibit
ABOUT THE EVENT The NIH mission is to expand fundamental knowledge about the nature and behavior of living systems and to improve and develop new strategies for the diagnosis, treatment, and prevention of disease and communicate the results of research with the goal of improving health. NIH works toward that mission by conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of…
Read MoreCGT Global Exhibiting at CAR-TCR Summit 2018
ABOUT THE EVENT Welcome to the 4th Annual CAR-TCR Summit 2018 Changing Lives with CAR-T & TCR Cell Immunotherapies The CAR-TCR Summit is the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies for solid tumor indications, whilst ensuring the accessibility and commercial delivery of currently approved life-changing CAR-TCR therapies to patients around the world. TO LEARN MORE, CLICK HERE.
Read MoreWhy use Clinical Grade Non-Transfusable products?
Why use Clinical Grade Non-Transfusable products? Within the last year, progress in cellular therapies have led to the restoration of eyesight, construction of new skin, a cure for sickle-cell, and the FDA approval of cancer-killing CAR-T cells, and it’s set to advance even further. However, these types of therapies can be hindered by the cost and time to develop. With some taking over 7 years and $2.5 billion to find their way to the FDA approval process, these new therapies may not…
Read More